| Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study KE Reeder‐Hayes, SE Mayer, AF Olshan, SB Wheeler, LA Carey, CK Tse, ... Cancer 125 (22), 3985-3992, 2019 | 50 | 2019 |
| Comparison of Medicare claims-based proxy measures of poor function and associations with treatment receipt and mortality in older colon cancer patients SE Mayer, HJ Tan, S Peacock Hinton, HK Sanoff, T Stürmer, LL Hester, ... Medical care 57 (4), 286-294, 2019 | 18 | 2019 |
| Adherence to endocrine therapy including ovarian suppression: a large observational cohort study of US women with early breast cancer KE Reeder‐Hayes, SE Mayer, JL Lund Cancer 127 (8), 1220-1227, 2021 | 12 | 2021 |
| CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy SE Mayer, NS Weiss, J Chubak, DR Doody, CS Carlson, KW Makar, ... Cancer Causes & Control 30, 103-112, 2019 | 12 | 2019 |
| Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008–2019 SN Levintow, SR Reading, S Noshad, SE Mayer, C Wiener, B Eledath, ... Clinical Epidemiology, 737-748, 2022 | 3 | 2022 |
| Medicare Claims-Based Measures of Poor Physical Function and Associations with Treatment and Mortality in Older Colon Cancer Patients SE Mayer, HJ Tan, SP Hinton, LL Hester, T Sturmer, KR Faurot, MJ Funk, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 174-174, 2017 | 1 | 2017 |
| Successful implementation of inverse-probability-of-screening weights to address differential outcome screening: effects of statin persistence on breast cancer risk in Denmark S Mayer, J Hallas, J Edwards, L Henderson, T Sturmer PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 4-5, 2022 | | 2022 |
| Lipid testing trends before and after hospitalization for myocardial infarction among adults in the US, 2008–2019 SN Levintow, SR Reading, S Noshad, S Mayer, C Wiener, B Eledath, ... European Heart Journal 42 (Supplement_1), ehab724. 2941, 2021 | | 2021 |
| Prevalence of osteoporosis and its treatment among women>= 50 in NHANES: 1999-2018 SE Mayer, LJ McGrath, M Kim, M McDermott, MA Brookhart PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 28-28, 2021 | | 2021 |
| Modeling drug treatment effects on breast cancer in the setting of differential screening SE Mayer, J Hallas, JK Edwards, JL Lund, LM Henderson, T Sturmer Pharmacoepidemiology and Drug Safety 30 (Suppl. 1), 275, 2021 | | 2021 |
| Differential cancer screening during follow-up as a source of bias in pharmacoepidemiology SE Mayer, JK Edwards, J Hallas, JL Lund, T Sturmer Pharmacoepidemiology and Drug Safety 29 (Suppl. 3), 362, 2020 | | 2020 |
| Antidepressant use and adherence among breast cancer patients using tamoxifen S Dejene, J Park, SE Mayer, A Kinlaw, HB Nichols, M Jonsson-Funk, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 270-271, 2020 | | 2020 |
| Antidepressant dispensing among women with breast cancer, United States, 2001-2018 J Park, S Dejene, SE Mayer, A Kinlaw, HB Nichols, M Jonsson-Funk, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 31-32, 2020 | | 2020 |
| Use of ovarian suppression with endocrine therapy among premenopausal women with breast cancer in the United States, 2001-2016 SE Mayer, JL Lund, V Pate, KE Reeder-Hayes PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 545-546, 2019 | | 2019 |
| North Carolina Opioid Overdose Polysubstance Trends, 2012-2017 SE Mayer, CS Wolff, A Ising, S Proescholdbell, A Waller 2019 CSTE Annual Conference, 2019 | | 2019 |
| Use of ovarian suppression with endocrine therapy among premenopausal United States women with breast cancer, 2001-2016. SE Mayer, JL Lund, V Pate, KE Reeder-Hayes Journal of Clinical Oncology 37 (15_suppl), e12010-e12010, 2019 | | 2019 |
| Improving claims-based frailty prediction in the medicare population using STOPPFrail drug criteria SE Mayer, V Pate, LC Hanson, MJ Funk, KR Faurot, T Sturmer, JL Lund PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 193-193, 2018 | | 2018 |
| Temporal patterns of breast cancer treatment initiation and completion among black and white women in the Carolina Breast Cancer Study. SE Mayer, M Troester, SB Wheeler, A Olshan, LA Carey, J Tse, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 51-52, 2018 | | 2018 |
| Abstract PR11: Temporal patterns of breast cancer treatment initiation and completion among black and white women in the Carolina Breast Cancer Study SE Mayer, M Troester, SB Wheeler, A Olshan, LA Carey, J Tse, ... Cancer Epidemiology, Biomarkers & Prevention 27 (7_Supplement), PR11-PR11, 2018 | | 2018 |
| Abstract P4-10-01: Race, place and delays in breast cancer treatment across the care continuum in the Carolina breast cancer study KE Reeder-Hayes, SE Mayer, A Olshan, LA Carey, SB Wheeler, CK Tse, ... Cancer Research 78 (4_Supplement), P4-10-01-P4-10-01, 2018 | | 2018 |
